Transparency is our policy. Learn how it impacts everything we do
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we make money
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we use your personal data
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
How we approach editorial content
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
Where is 20/20 GeneSystems located?
20/20 GeneSystems is a US based private corporation located in Maryland. Investment opportunities are currently available and as a Reg A+ company, anyone can become a shareholder in our company as well and we have raised more than $5m in equity crowd funding, making us one of the most successful crowd-funding life science companies in history. Additional opportunities are available for traditional accredited investors, family offices, private equity and venture capital firms. While our operations are global today our biggest markets are the United States and Asia.
What is 20/20 diagnostics?
20/20 GeneSystems is a digital diagnostics company with the core mission of reducing cancer mortality in the U.S. and around the world through early detection. We believe in developing cutting edge solutions through combining innovation with well researched established procedures.
